EUR/USD 1.19165
0.185%
Gold 5061.91
0.729%
Oil 64.677
1.010%
USD/JPY 153.172
-0.785%
GBP/USD 1.36935
0.380%
GBP/JPY 209.751
-0.399%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
February 11th - The National Health Commission and 11 other departments jointly issued the "Administrative Measures for the National Essential Medicines List" today. Compared with the previous document, the "Administrative Measures for the National Essential Medicines List" clarifies that adjustments to the types and quantities of essential medicines will be made based on changes in disease patterns, clinical application practices, changes in drug standards, and new drug launches, adhering to the principles of giving equal importance to traditional Chinese and Western medicine and prioritizing clinical application. It also comprehensively considers factors such as my countrys basic medical and health service needs, basic medical security levels, and drug supply security. The measures standardize the dynamic adjustment mechanism, strengthen the functional positioning of essential medicines, adhere to regular evaluation and dynamic management, and stipulate that the adjustment cycle should generally not exceed three years, with adjustments possible as needed.February 11th - The National Health Commission and 11 other departments jointly issued the "Administrative Measures for the National Essential Medicines List" today. Compared with the previous document, the "Administrative Measures for the National Essential Medicines List" adds legal and policy basis. It adds the "Basic Medical and Health Care and Health Promotion Law," the "Drug Administration Law," and other higher-level laws as legal basis, and aligns with policies such as the "Opinions of the General Office of the State Council on Improving the National Essential Medicines System" and the "Opinions of the General Office of the State Council on Further Improving the Supply and Price Stabilization of Shortage Drugs." The list structure is rationally optimized. National essential medicines are divided into chemical drugs and biological products, and traditional Chinese medicine (processed medicinal herbs and prepared Chinese medicines). Chemical drugs and biological products are mainly classified according to clinical pharmacology, while prepared Chinese medicines are mainly classified according to function.February 11th - The Peoples Bank of China released its 2025 financial market operation report. In 2025, the amount of commercial bill acceptances reached 42.7 trillion yuan, and the amount of discounting reached 33.9 trillion yuan. As of the end of 2025, the outstanding balance of commercial bill acceptances was 21.2 trillion yuan, an increase of 7.2% compared to the end of 2024; the outstanding balance of discounting was 16.5 trillion yuan, an increase of 11.2% compared to the end of 2024.The European Commission will take measures to improve drone detection capabilities.The Russian Foreign Ministry stated that if the United States complies with the quantity limits of the New START Treaty, Russias position of suspending its actions that exceed the treatys limits will remain unchanged.

S&P 500 Weekly Price Forecast – S&P 500 Breakthrough Resistance Barrier

Alice Wang

Nov 14, 2022 16:46

微信截图_20221114164244.png

Weekly Technical Analysis for the S&P 500

The S&P 500 E-mini contract has gained quite a bit this week as speculation about the Federal Reserve relaxing monetary policy has increased. Despite the fact that the US inflation rate came in at 7.7% year-over-year, it is difficult to foresee a scenario in which the Federal Reserve will ease monetary policy. In light of this, we now find ourselves in a scenario where the market has seized the initiative.


Before it's all said and done, I predict there will be a lot of dissatisfied traders. I view this situation through the lens of a "bear market rally."


Remember that some of the most volatile sessions take place in the middle of a bear market because traders were waiting for an excuse to go long and found it over the trading week. Whether or not that holds true moving forward, that will be entirely different. In the end, it's feasible that we could swiftly return to the 3700 level if we were to reverse course and break down below the 3950 level. On the other hand, we might have a potential figure breakout if we were to break above the 4050 level, which is where the 50-Week EMA is now located.


In the end, it's still uncertain whether this market has just produced a small "double bottom."


Remembering that we have been in a decline channel for some time is also important. Ultimately, I believe that there will be a great deal of volatility.

Suggestion